Skip to main content

Table 3 Mean and 95% confidence intervals (CIs) for costs, mortality and QALYs, at 90 days and 10 years for London per 1000 patients

From: The potential role of cost-utility analysis in the decision to implement major system change in acute stroke services in metropolitan areas in England

 

London

England

DID

Before

After

Difference

Before

After

Difference

90-day results

 Deaths

100 (80 to 120)

75 (56 to 92)

−25 (−41 to − 10)

114 (93 to 133)

97 (79 to 115)

−17 (−21 to − 12)

−9 (−24 to 6)

 LOS

19 (18 to 20)

16 (15 to 17)

−3 (−4 to −3)

20 (18 to 21)

17 (16 to 18)

−3 (−3 to −2)

−1 (−1 to 0)

 QALYs

102 (96 to 108)

110 (88 to 132)

8 (−14 to 29)

100 (93 to 106)

104 (98 to 110)

4 (4 to 5)

3.6 (−18 to 25)

 Costs

£5,705,774 (£4,598,498 to £6,813,049)

£5,949,155 (£5,069,827 to £6,828,484)

£243,381 (−£182,658 to £669,421)

£5,492,431 (£4,394,421 to £6,590,440)

£4,965,785 (£3,956,766 to £5,974,803)

−£526,646 (−£640,210 to −£413,081)

£770,027 (£392,152 to £1,147,902)

10-year results

 Deaths

386 (316 to 455)

360 (289 to 432)

−25 (−38 to −13)

417 (351 to 483)

401 (329 to 475)

−15 (−44 to 13)

−10 (−37 to 17)

 QALYs

2931 (2499 to 3363)

3473 (3079 to 3867)

542 (109 to 975)

2802 (2391 to 3214)

3287 (2909 to 3665)

484 (66 to 903)

58 (−76 to 193)

 Costs

£39,459,874 (£29,343,049 to £49,576,698)

£38,146,542 (£27,941,281 to £48,351,802)

–£1,313,332 (−£5,315,567 £2,688,902)

£39,818,504 (£29,562,087 to £50,074,921)

£37,490,809 (£27,170,660 to £47,810,958)

–£2,327,696 (−£6,146,669 to £1,491,278)

£1,014,363 (£19,462 to £2,009,264)

 NMB £20,000 per QALY (per patient)

  

£12,163 (£5 to £24,321)

  

£12,015 (£338 to £23,692)

£148 (−£2208 to £2504)

  1. LOS length of stay, QALYs quality adjusted life years, DID difference-in-difference, NMB net monetary benefit